Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha (Q73807671)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1997

Language	Label	Description	Also known as
English	Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha	scientific article published on 01 October 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Intravesical immunoprophylaxis in recurrent superficial bladder cancer (Stage T1): multicenter trial comparing bacille Calmette-Guérin and interferon-alpha (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

César David Vera-Donoso

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

J F Jimenez-Cruz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

O Leiva

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Pamplona

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L A Rioja-Sanz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Martinez-Lasierra

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

N Flores

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

529-535

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

An overview of intravesical therapy for superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bladder cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial of bacillus Calmette-Guérin versus adriamycin in superficial bladder cancer: a South-West Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of superficial bladder tumors with intravesical recombinant interferon alpha-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

T1 Bladder Tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Superficial bladder cancer: progression and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Requirement of a thymus dependent immune response for BCG-mediated antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled study of intravesical alpha-2b-interferon in carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoprophylaxis with Calmette-Guérin bacillus in recurrent superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravesical Chemotherapy (Mitomycin C) versus Immunotherapy (Bacillus Calmette-Guérin) in Superficial Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravesical bacillus Calmette-Guerin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

BCG in perspective: advances in the treatment of superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

BCG therapy in superficial bladder tumours--complications and precautions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

How effective is topical alpha-2b interferon in preventing recurrence of superficial bladder cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravesical bacillus Calmette-Guerin for patients with high-risk superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900303-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(97)00303-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9338727%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73807671&oldid=2236924943"